L’accumulation des articles sur la différence entre hypnotique intraveineux (propofol) ou inhalé (halogéné) ces dernières années me turlupine. Il semble que le propofol soit protecteur lors d’une chirurgie pour cancer. Les patients vivraient plus vieux, avec moins de localisations secondaires.On ne peut pas être anesthésiste, s’occuper de patients avec un cancer et ne pas lire l’article de Nature Reviews de Hiller.
Vu le peu débat possible sur une éventuelle supériorité des halogénés sur un autre volet de la santé des patients, mon choix va désormais se porter sur le propofol en SAP pour les patients atteints d’un cancer donc je vais m’occuper. Plusieurs études randomisées sont en cours, je vais suivre de près les résultats. Chez vous ça se passe comment ? Une réflexion est-elle menée ?
858234
XNKUVUGU
items
1
0
default
asc
1
8239
https://www.nfkb0.com/wp-content/plugins/zotpress/
%7B%22status%22%3A%22success%22%2C%22updateneeded%22%3Afalse%2C%22instance%22%3A%22zotpress-28c7761c0f251bc1bb9b016979f8c613%22%2C%22meta%22%3A%7B%22request_last%22%3A0%2C%22request_next%22%3A0%2C%22used_cache%22%3Atrue%7D%2C%22data%22%3A%5B%7B%22key%22%3A%22PTYXDK9I%22%2C%22library%22%3A%7B%22id%22%3A858234%7D%2C%22meta%22%3A%7B%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3E%3Ci%3EGeneral%20Anesthetics%20in%20CAncer%20REsection%20Surgery%20%28GA-CARES%29%20Trial%20-%20Full%20Text%20View%20-%20ClinicalTrials.gov%3C%5C%2Fi%3E.%20%28n.d.%29.%20Retrieved%20December%203%2C%202018%2C%20from%20%3Ca%20href%3D%27https%3A%5C%2F%5C%2Fclinicaltrials.gov%5C%2Fct2%5C%2Fshow%5C%2FNCT03034096%27%3Ehttps%3A%5C%2F%5C%2Fclinicaltrials.gov%5C%2Fct2%5C%2Fshow%5C%2FNCT03034096%3C%5C%2Fa%3E%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22webpage%22%2C%22title%22%3A%22General%20Anesthetics%20in%20CAncer%20REsection%20Surgery%20%28GA-CARES%29%20Trial%20-%20Full%20Text%20View%20-%20ClinicalTrials.gov%22%2C%22creators%22%3A%5B%5D%2C%22abstractNote%22%3A%22General%20Anesthetics%20in%20CAncer%20REsection%20Surgery%20%28GA-CARES%29%20Trial%20-%20Full%20Text%20View.%22%2C%22date%22%3A%22%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fclinicaltrials.gov%5C%2Fct2%5C%2Fshow%5C%2FNCT03034096%22%2C%22language%22%3A%22en%22%2C%22collections%22%3A%5B%22XNKUVUGU%22%5D%2C%22dateModified%22%3A%222018-12-03T13%3A22%3A16Z%22%7D%7D%2C%7B%22key%22%3A%22J4QLQPAZ%22%2C%22library%22%3A%7B%22id%22%3A858234%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Wigmore%20et%20al.%22%2C%22parsedDate%22%3A%222016-01%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3EWigmore%2C%20T.%20J.%2C%20Mohammed%2C%20K.%2C%20%26amp%3B%20Jhanji%2C%20S.%20%282016%29.%20Long-term%20Survival%20for%20Patients%20Undergoing%20Volatile%20versus%20IV%20Anesthesia%20for%20Cancer%20Surgery%3A%20A%20Retrospective%20Analysis.%20%3Ci%3EAnesthesiology%3C%5C%2Fi%3E%2C%20%3Ci%3E124%3C%5C%2Fi%3E%281%29%2C%2069%26%23x2013%3B79.%20%3Ca%20href%3D%27https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1097%5C%2FALN.0000000000000936%27%3Ehttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1097%5C%2FALN.0000000000000936%3C%5C%2Fa%3E%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Long-term%20Survival%20for%20Patients%20Undergoing%20Volatile%20versus%20IV%20Anesthesia%20for%20Cancer%20Surgery%3A%20A%20Retrospective%20Analysis%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Timothy%20J.%22%2C%22lastName%22%3A%22Wigmore%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kabir%22%2C%22lastName%22%3A%22Mohammed%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Shaman%22%2C%22lastName%22%3A%22Jhanji%22%7D%5D%2C%22abstractNote%22%3A%22BACKGROUND%3A%20Surgical%20resection%20remains%20the%20best%20option%20for%20long-term%20survival%20in%20many%20solid%20tumors.%20Surgery%20can%2C%20however%2C%20lead%20to%20tumor%20cell%20release%20into%20the%20circulation.%20Data%20have%20suggested%20differential%20effects%20of%20anesthetic%20agents%20on%20cancer%20cell%20growth.%20This%20retrospective%20analysis%20investigated%20the%20association%20of%20anesthetic%20technique%20with%20long-term%20survival%20in%20patients%20presenting%20for%20elective%20surgery%20in%20a%20comprehensive%20cancer%20center%20over%203%20yr.%5CnMETHODS%3A%20All%20patients%20undergoing%20elective%20surgery%20between%20June%202010%20and%20May%202013%20were%20included.%20Patients%20were%20grouped%20according%20to%20whether%20they%20had%20received%20volatile%20inhalational%20%28INHA%29%20or%20total%20IV%20anesthesia%20%28TIVA%29.%20After%20excluding%20those%20who%20received%20both%20forms%20of%20anesthesia%20during%20the%20study%20period%2C%20Kaplan-Meier%20survival%20curves%20were%20constructed%20from%20the%20date%20of%20surgery%20to%20death.%20After%20propensity%20matching%2C%20univariate%20and%20multivariable%20regression%20models%20were%20used%20to%20compare%20hazard%20ratios%20for%20death.%5CnRESULTS%3A%20A%20total%20of%2011%2C395%20anesthetics%20using%20INHA%20or%20TIVA%20were%20delivered%20in%20the%20study%20period.%20After%20exclusions%2C%203%2C316%20patients%20%28796%20deaths%2C%2024%25%29%20remained%20in%20the%20INHA%20group%20and%203%2C714%20%28504%20deaths%2C%2013.5%25%29%20in%20the%20TIVA%20group.%20After%20propensity%20matching%2C%202%2C607%20patients%20remained%20in%20each%20group%20%28597%20deaths%2C%2022.8%25%2C%20in%20INHA%20group%20vs.%20407%2C%2015.6%25%2C%20in%20TIVA%20group%29.%20Volatile%20inhalational%20anesthesia%20was%20associated%20with%20a%20hazard%20ratio%20of%201.59%20%281.30%20to%201.95%29%20for%20death%20on%20univariate%20analysis%20and%201.46%20%281.29%20to%201.66%29%20after%20multivariable%20analysis%20of%20known%20confounders%20in%20the%20matched%20group.%5CnCONCLUSIONS%3A%20This%20retrospective%20analysis%20demonstrates%20an%20association%20between%20type%20of%20anesthetic%20delivered%20and%20survival.%20This%20analysis%20alongside%20biological%20plausibility%20should%20lead%20to%20urgent%20prospective%20work%20exploring%20the%20effect%20of%20anesthetic%20technique%20on%20survival.%22%2C%22date%22%3A%22Jan%202016%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1097%5C%2FALN.0000000000000936%22%2C%22ISSN%22%3A%221528-1175%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22XNKUVUGU%22%5D%2C%22dateModified%22%3A%222018-12-03T13%3A12%3A31Z%22%7D%7D%2C%7B%22key%22%3A%22ZL7CDSCU%22%2C%22library%22%3A%7B%22id%22%3A858234%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Wu%20et%20al.%22%2C%22parsedDate%22%3A%222018-11%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3EWu%2C%20Z.-F.%2C%20Lee%2C%20M.-S.%2C%20Wong%2C%20C.-S.%2C%20Lu%2C%20C.-H.%2C%20Huang%2C%20Y.-S.%2C%20Lin%2C%20K.-T.%2C%20Lou%2C%20Y.-S.%2C%20Lin%2C%20C.%2C%20Chang%2C%20Y.-C.%2C%20%26amp%3B%20Lai%2C%20H.-C.%20%282018%29.%20Propofol-based%20Total%20Intravenous%20Anesthesia%20Is%20Associated%20with%20Better%20Survival%20Than%20Desflurane%20Anesthesia%20in%20Colon%20Cancer%20Surgery.%20%3Ci%3EAnesthesiology%3C%5C%2Fi%3E%2C%20%3Ci%3E129%3C%5C%2Fi%3E%285%29%2C%20932%26%23x2013%3B941.%20%3Ca%20href%3D%27https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1097%5C%2FALN.0000000000002357%27%3Ehttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1097%5C%2FALN.0000000000002357%3C%5C%2Fa%3E%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Propofol-based%20Total%20Intravenous%20Anesthesia%20Is%20Associated%20with%20Better%20Survival%20Than%20Desflurane%20Anesthesia%20in%20Colon%20Cancer%20Surgery%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Zhi-Fu%22%2C%22lastName%22%3A%22Wu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Meei-Shyuan%22%2C%22lastName%22%3A%22Lee%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Chih-Shung%22%2C%22lastName%22%3A%22Wong%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Chueng-He%22%2C%22lastName%22%3A%22Lu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yuan-Shiou%22%2C%22lastName%22%3A%22Huang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kuen-Tze%22%2C%22lastName%22%3A%22Lin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yu-Sheng%22%2C%22lastName%22%3A%22Lou%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Chin%22%2C%22lastName%22%3A%22Lin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yue-Cune%22%2C%22lastName%22%3A%22Chang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Hou-Chuan%22%2C%22lastName%22%3A%22Lai%22%7D%5D%2C%22abstractNote%22%3A%22WHAT%20WE%20ALREADY%20KNOW%20ABOUT%20THIS%20TOPIC%3A%20WHAT%20THIS%20ARTICLE%20TELLS%20US%20THAT%20IS%20NEW%3A%20BACKGROUND%3A%3A%20Previous%20research%20has%20shown%20different%20effects%20of%20anesthetics%20on%20cancer%20cell%20growth.%20Here%2C%20the%20authors%20investigated%20the%20association%20between%20type%20of%20anesthetic%20and%20patient%20survival%20after%20elective%20colon%20cancer%20surgery.%5CnMETHODS%3A%20A%20retrospective%20cohort%20study%20included%20patients%20who%20received%20elective%20colon%20cancer%20surgery%20between%20January%202005%20and%20December%202014.%20Patients%20were%20grouped%20according%20to%20anesthesia%20received%3A%20propofol%20or%20desflurane.%20After%20exclusion%20of%20those%20who%20received%20combined%20propofol%20anesthesia%20with%20inhalation%20anesthesia%20or%20epidural%20anesthesia%2C%20survival%20curves%20were%20constructed%20from%20the%20date%20of%20surgery%20to%20death.%20After%20propensity%20matching%2C%20univariable%20and%20multivariable%20Cox%20regression%20models%20were%20used%20to%20compare%20hazard%20ratios%20for%20death.%20Subgroup%20analyses%20were%20performed%20for%20tumor-node-metastasis%20staging%20and%20postoperative%20metastasis.%5CnRESULTS%3A%20A%20total%20of%20706%20patients%20%28307%20deaths%2C%2043.5%25%29%20with%20desflurane%20anesthesia%20and%20657%20%2888%20deaths%2C%2013.4%25%29%20with%20propofol%20anesthesia%20were%20eligible%20for%20analysis.%20After%20propensity%20matching%2C%20579%20patients%20remained%20in%20each%20group%20%28189%20deaths%2C%2032.6%25%2C%20in%20the%20desflurane%20group%20vs.%2087%2C%2015.0%25%2C%20in%20the%20propofol%20group%29.%20In%20the%20matched%20analyses%2C%20the%20propofol-treated%20group%20had%20a%20better%20survival%2C%20irrespective%20of%20lower%20tumor-node-metastasis%20stage%20%28hazard%20ratio%2C%200.22%3B%2095%25%20CI%2C%200.11%20to%200.42%3B%20P%20%3C%200.001%29%20or%20higher%20tumor-node-metastasis%20stage%20%28hazard%20ratio%2C%200.42%3B%2095%25%20CI%2C%200.32%20to%200.55%3B%20P%20%3C%200.001%29%20and%20presence%20of%20metastases%20%28hazard%20ratio%2C%200.67%3B%2095%25%20CI%2C%200.51%20to%200.86%3B%20P%20%3D%200.002%29%20or%20absence%20of%20metastases%20%28hazard%20ratio%2C%200.08%3B%2095%25%20CI%2C%200.01%20to%200.62%3B%20P%20%3D%200.016%29.%20Simple%20propensity%20score%20adjustment%20produced%20similar%20findings.%5CnCONCLUSIONS%3A%20Propofol%20anesthesia%20for%20colon%20cancer%20surgery%20is%20associated%20with%20better%20survival%20irrespective%20of%20tumor-node-metastasis%20stage.%22%2C%22date%22%3A%22Nov%202018%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1097%5C%2FALN.0000000000002357%22%2C%22ISSN%22%3A%221528-1175%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22XNKUVUGU%22%5D%2C%22dateModified%22%3A%222018-12-03T13%3A12%3A01Z%22%7D%7D%2C%7B%22key%22%3A%22IAUC3KGD%22%2C%22library%22%3A%7B%22id%22%3A858234%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Zheng%20et%20al.%22%2C%22parsedDate%22%3A%222018-03-01%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3EZheng%2C%20X.%2C%20Wang%2C%20Y.%2C%20Dong%2C%20L.%2C%20Zhao%2C%20S.%2C%20Wang%2C%20L.%2C%20Chen%2C%20H.%2C%20Xu%2C%20Y.%2C%20%26amp%3B%20Wang%2C%20G.%20%282018%2C%20March%201%29.%20%3Ci%3EEffects%20of%20propofol-based%20total%20intravenous%20anesthesia%20on%20gastric%20cancer%3A%20a%20retrospective%20study%3C%5C%2Fi%3E.%20OncoTargets%20and%20Therapy.%20https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.2147%5C%2FOTT.S156792%20%3Ca%20title%3D%27Download%27%20class%3D%27zp-DownloadURL%27%20href%3D%27https%3A%5C%2F%5C%2Fwww.nfkb0.com%5C%2Fwp-content%5C%2Fplugins%5C%2Fzotpress%5C%2Flib%5C%2Frequest%5C%2Frequest.dl.php%3Fapi_user_id%3D858234%26amp%3Bdlkey%3DLTGXV2SZ%26amp%3Bcontent_type%3Dapplication%5C%2Fpdf%27%3EDownload%3C%5C%2Fa%3E%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22webpage%22%2C%22title%22%3A%22Effects%20of%20propofol-based%20total%20intravenous%20anesthesia%20on%20gastric%20cancer%3A%20a%20retrospective%20study%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Xiaoyu%22%2C%22lastName%22%3A%22Zheng%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yu%22%2C%22lastName%22%3A%22Wang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Linlin%22%2C%22lastName%22%3A%22Dong%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Su%22%2C%22lastName%22%3A%22Zhao%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Liping%22%2C%22lastName%22%3A%22Wang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Hong%22%2C%22lastName%22%3A%22Chen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yang%22%2C%22lastName%22%3A%22Xu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Guonian%22%2C%22lastName%22%3A%22Wang%22%7D%5D%2C%22abstractNote%22%3A%22Effects%20of%20propofol-based%20total%20intravenous%20anesthesia%20on%20gastric%20cancer%3A%20a%20retrospective%20study%20Xiaoyu%20Zheng%2C1%20Yu%20Wang%2C1%20Linlin%20Dong%2C1%20Su%20Zhao%2C2%20Liping%20Wang%2C1%20Hong%20Chen%2C1%20Yang%20Xu%2C1%20Guonian%20Wang1%20%201Department%20of%20Anesthesiology%2C%20Harbin%20Medical%20University%20Cancer%20Hospital%2C%20Harbin%2C%20China%3B%202Department%20of%20Thoracic%20Surgery%2C%20Harbin%20Medical%20University%20Cancer%20Hospital%2C%20Harbin%2C%20China%20%20Background%3A%20Several%20kinds%20of%20cancer%20surgeries%20with%20propofol-based%20total%20intravenous%20anesthesia%20%28TIVA%29%20have%20been%20shown%20to%20have%20better%20outcomes%20than%20those%20with%20sevoflurane-based%20inhalational%20anesthesia%20%28INHA%29.%20However%2C%20the%20effects%20of%20this%20anesthetic%20technique%20have%20not%20been%20investigated%20in%20patients%20with%20gastric%20cancer.%20In%20this%20study%2C%20the%20authors%20retrospectively%20examined%20the%20link%20between%20the%20choice%20of%20anesthetic%20technique%20and%20overall%20survival%20in%20patients%20undergoing%20gastric%20cancer%20resection.%20Methods%3A%20We%20conducted%20a%20retrospective%20analysis%20of%20the%20database%20of%20all%20patients%20undergoing%20gastric%20cancer%20resection%20for%20gastric%20cancer%20between%202007%20and%202012.%20Patients%20who%20received%20TIVA%20or%20INHA%20were%20administered%20patient-controlled%20intravenous%20analgesia%20for%2072%26ndash%3B120%20hours%20postoperatively.%20Survival%20was%20estimated%20using%20the%20Kaplan%26ndash%3BMeier%20log-rank%20test%2C%20and%20associations%20between%20anesthetic%20technique%20and%20outcomes%20were%20analyzed%20using%20Cox%20proportional%20hazards%20regressions%20after%20propensity%20matching.%20Results%3A%20A%20total%20of%202%2C856%20anesthetics%20using%20INHA%20or%20TIVA%20were%20delivered%20in%20the%20study%20period.%20After%20propensity%20matching%2C%20897%20patients%20remained%20in%20each%20group.%20According%20to%20Kaplan%26ndash%3BMeier%20analysis%2C%20the%20use%20of%20TIVA%20was%20associated%20with%20improved%20survival%20%28P%26lt%3B0.001%29.%20TIVA%20was%20associated%20with%20a%20hazard%20ratio%20%28HR%29%20of%200.67%20%2895%25%20confidence%20interval%20%5BCI%5D%3A%200.58%26ndash%3B0.77%29%20for%20death%20in%20univariate%20analysis%20and%200.65%20%2895%25%20CI%3A%200.56%26ndash%3B0.75%29%20after%20a%20multivariate%20analysis%20of%20known%20confounders%20in%20the%20matched%20group.%20Cancer%20stage%20%28HR%20%3D0.74%2C%2095%25%20CI%3A%200.64%26ndash%3B0.86%2C%26nbsp%3BP%26lt%3B0.001%29%20and%20degree%20of%20differentiation%20%28HR%20%3D1.28%2C%2095%25%20CI%3A%201.11%26ndash%3B1.47%2C%20P%26lt%3B0.001%29%20were%20also%20associated%20with%20survival%20in%20the%20univariate%20analysis%20in%20the%20matched%20group.%20In%20the%20multivariable%20Cox%20model%2C%20cancer%20stage%20%28HR%20%3D0.72%2C%2095%25%20CI%3A%200.62%26ndash%3B0.84%2C%26nbsp%3BP%26lt%3B0.001%29%20and%20degree%20of%20differentiation%20%28HR%20%3D1.23%2C%2095%25%20CI%3A%201.07%26ndash%3B1.42%2C%26nbsp%3BP%26lt%3B0.001%29%20were%20associated%20with%20survival%20in%20the%20matched%20group.%20Conclusion%3A%20These%20results%20indicate%20that%20TIVA%20may%20be%20associated%20with%20improved%20survival%20in%20gastric%20cancer%20patients%20who%20undergo%20resection.%20%20Keywords%3A%20anesthesia%2C%20propofol%2C%20sevoflurane%2C%20patient-controlled%20analgesia%2C%20gastric%20cancer%2C%20overall%20survival%22%2C%22date%22%3A%222018%5C%2F03%5C%2F01%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fwww.dovepress.com%5C%2Feffects-of-propofol-based-total-intravenous-anesthesia-on-gastric-canc-peer-reviewed-article-OTT%22%2C%22language%22%3A%22English%22%2C%22collections%22%3A%5B%22XNKUVUGU%22%5D%2C%22dateModified%22%3A%222018-12-03T13%3A12%3A00Z%22%7D%7D%2C%7B%22key%22%3A%22TCBQ4XZ8%22%2C%22library%22%3A%7B%22id%22%3A858234%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Hiller%20et%20al.%22%2C%22parsedDate%22%3A%222018-04%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3EHiller%2C%20J.%20G.%2C%20Perry%2C%20N.%20J.%2C%20Poulogiannis%2C%20G.%2C%20Riedel%2C%20B.%2C%20%26amp%3B%20Sloan%2C%20E.%20K.%20%282018%29.%20Perioperative%20events%20influence%20cancer%20recurrence%20risk%20after%20surgery.%20%3Ci%3ENature%20Reviews%20Clinical%20Oncology%3C%5C%2Fi%3E%2C%20%3Ci%3E15%3C%5C%2Fi%3E%284%29%2C%20205%26%23x2013%3B218.%20%3Ca%20href%3D%27https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1038%5C%2Fnrclinonc.2017.194%27%3Ehttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1038%5C%2Fnrclinonc.2017.194%3C%5C%2Fa%3E%20%3Ca%20title%3D%27Download%27%20class%3D%27zp-DownloadURL%27%20href%3D%27https%3A%5C%2F%5C%2Fwww.nfkb0.com%5C%2Fwp-content%5C%2Fplugins%5C%2Fzotpress%5C%2Flib%5C%2Frequest%5C%2Frequest.dl.php%3Fapi_user_id%3D858234%26amp%3Bdlkey%3DUZY6LYVQ%26amp%3Bcontent_type%3Dapplication%5C%2Fpdf%27%3EDownload%3C%5C%2Fa%3E%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Perioperative%20events%20influence%20cancer%20recurrence%20risk%20after%20surgery%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jonathan%20G.%22%2C%22lastName%22%3A%22Hiller%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nicholas%20J.%22%2C%22lastName%22%3A%22Perry%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22George%22%2C%22lastName%22%3A%22Poulogiannis%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Bernhard%22%2C%22lastName%22%3A%22Riedel%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Erica%20K.%22%2C%22lastName%22%3A%22Sloan%22%7D%5D%2C%22abstractNote%22%3A%22Surgery%20is%20a%20mainstay%20treatment%20for%20patients%20with%20solid%20tumours.%20However%2C%20despite%20surgical%20resection%20with%20a%20curative%20intent%20and%20numerous%20advances%20in%20the%20effectiveness%20of%20%28neo%29adjuvant%20therapies%2C%20metastatic%20disease%20remains%20common%20and%20carries%20a%20high%20risk%20of%20mortality.%20The%20biological%20perturbations%20that%20accompany%20the%20surgical%20stress%20response%20and%20the%20pharmacological%20effects%20of%20anaesthetic%20drugs%2C%20paradoxically%2C%20might%20also%20promote%20disease%20recurrence%20or%20the%20progression%20of%20metastatic%20disease.%20When%20cancer%20cells%20persist%20after%20surgery%2C%20either%20locally%20or%20at%20undiagnosed%20distant%20sites%2C%20neuroendocrine%2C%20immune%2C%20and%20metabolic%20pathways%20activated%20in%20response%20to%20surgery%20and%5C%2For%20anaesthesia%20might%20promote%20their%20survival%20and%20proliferation.%20A%20consequence%20of%20this%20effect%20is%20that%20minimal%20residual%20disease%20might%20then%20escape%20equilibrium%20and%20progress%20to%20metastatic%20disease.%20Herein%2C%20we%20discuss%20the%20most%20promising%20proposals%20for%20the%20refinement%20of%20perioperative%20care%20that%20might%20address%20these%20challenges.%20We%20outline%20the%20rationale%20and%20early%20evidence%20for%20the%20adaptation%20of%20anaesthetic%20techniques%20and%20the%20strategic%20use%20of%20anti-adrenergic%2C%20anti-inflammatory%2C%20and%5C%2For%20antithrombotic%20therapies.%20Many%20of%20these%20strategies%20are%20currently%20under%20evaluation%20in%20large-cohort%20trials%20and%20hold%20promise%20as%20affordable%2C%20readily%20available%20interventions%20that%20will%20improve%20the%20postoperative%20recurrence-free%20survival%20of%20patients%20with%20cancer.%22%2C%22date%22%3A%222018-04%22%2C%22language%22%3A%22en%22%2C%22DOI%22%3A%2210.1038%5C%2Fnrclinonc.2017.194%22%2C%22ISSN%22%3A%221759-4782%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fwww.nature.com%5C%2Farticles%5C%2Fnrclinonc.2017.194%22%2C%22collections%22%3A%5B%22XNKUVUGU%22%5D%2C%22dateModified%22%3A%222018-12-03T13%3A11%3A28Z%22%7D%7D%2C%7B%22key%22%3A%22Z78NCZSZ%22%2C%22library%22%3A%7B%22id%22%3A858234%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Sekandarzad%20et%20al.%22%2C%22parsedDate%22%3A%222017-05%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3ESekandarzad%2C%20M.%20W.%2C%20van%20Zundert%2C%20A.%20A.%20J.%2C%20Lirk%2C%20P.%20B.%2C%20Doornebal%2C%20C.%20W.%2C%20%26amp%3B%20Hollmann%2C%20M.%20W.%20%282017%29.%20Perioperative%20Anesthesia%20Care%20and%20Tumor%20Progression.%20%3Ci%3EAnesthesia%20%26amp%3B%20Analgesia%3C%5C%2Fi%3E%2C%20%3Ci%3E124%3C%5C%2Fi%3E%285%29%2C%201697.%20%3Ca%20href%3D%27https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1213%5C%2FANE.0000000000001652%27%3Ehttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1213%5C%2FANE.0000000000001652%3C%5C%2Fa%3E%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Perioperative%20Anesthesia%20Care%20and%20Tumor%20Progression%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mir%20W.%22%2C%22lastName%22%3A%22Sekandarzad%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Andr%5Cu00e9%20A.%20J.%22%2C%22lastName%22%3A%22van%20Zundert%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Philipp%20B.%22%2C%22lastName%22%3A%22Lirk%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Chris%20W.%22%2C%22lastName%22%3A%22Doornebal%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Markus%20W.%22%2C%22lastName%22%3A%22Hollmann%22%7D%5D%2C%22abstractNote%22%3A%22This%20narrative%20review%20discusses%20the%20most%20recent%20up-to-date%20findings%20focused%20on%20the%20currently%20available%20%5Cu201cbest%20clinical%20practice%5Cu201d%20regarding%20perioperative%20anesthesia%20care%20bundle%20factors%20and%20their%20effect%20on%20tumor%20progression.%20The%20main%20objective%20is%20to%20critically%20appraise%20the%20current%20literature%20on%20local%20anesthetics%2C%20regional%20outcome%20studies%2C%20opioids%2C%20and%20nonsteroidal%20anti-inflammatory%20drugs%20%28NSAIDs%29%20and%20their%20ability%20to%20decrease%20recurrence%20in%20patients%20undergoing%20cancer%20surgery.%20A%20brief%20discussion%20of%20additional%20topical%20perioperative%20factors%20relevant%20to%20the%20anesthesiologist%20including%20volatile%20and%20intravenous%20anesthetics%2C%20perioperative%20stress%20and%20anxiety%2C%20nutrition%2C%20and%20immune%20stimulation%20is%20included.%20The%20results%20of%20several%20recently%20published%20systematic%20reviews%20looking%20at%20the%20association%20between%20cancer%20recurrences%20and%20regional%20anesthesia%20have%20yielded%20inconclusive%20data%20and%20provide%20insufficient%20evidence%20regarding%20a%20definitive%20benefit%20of%20regional%20anesthesia.%20Basic%20science%20data%20suggests%20an%20anti%20tumor%20effect%20induced%20by%20local%20anesthetics.%20New%20refined%20animal%20models%20show%20that%20opioids%20can%20safely%20be%20used%20for%20perioperative%20pain%20management.%20Preliminary%20evidence%20suggests%20that%20NSAIDs%20should%20be%20an%20essential%20part%20of%20multimodal%20analgesia.%20Volatile%20anesthetics%20have%20been%20shown%20to%20increase%20tumor%20formation%2C%20whereas%20preclinical%20and%20emerging%20clinical%20data%20from%20propofol%20indicate%20tumor%20protective%20qualities.%20The%20perioperative%20period%20in%20the%20cancer%20patient%20represents%20a%20unique%20environment%20where%20surgically%20mediated%20stress%20response%20leads%20to%20immune%20suppression.%20Regional%20anesthesia%20techniques%20when%20indicated%20in%20combination%20with%20multimodal%20analgesia%20that%20include%20NSAIDs%2C%20opioids%2C%20and%20local%20anesthetics%20to%20prevent%20the%20pathophysiologic%20effects%20of%20pain%20and%20neuroendocrine%20stress%20response%20should%20be%20viewed%20as%20an%20essential%20part%20of%20balanced%20anesthesia.%22%2C%22date%22%3A%22May%202017%22%2C%22language%22%3A%22en-US%22%2C%22DOI%22%3A%2210.1213%5C%2FANE.0000000000001652%22%2C%22ISSN%22%3A%220003-2999%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fjournals.lww.com%5C%2Fanesthesia-analgesia%5C%2FFulltext%5C%2F2017%5C%2F05000%5C%2FPerioperative_Anesthesia_Care_and_Tumor.49.aspx%22%2C%22collections%22%3A%5B%22XNKUVUGU%22%5D%2C%22dateModified%22%3A%222018-12-03T13%3A09%3A59Z%22%7D%7D%5D%7D
General Anesthetics in CAncer REsection Surgery (GA-CARES) Trial - Full Text View - ClinicalTrials.gov. (n.d.). Retrieved December 3, 2018, from https://clinicaltrials.gov/ct2/show/NCT03034096
Wigmore, T. J., Mohammed, K., & Jhanji, S. (2016). Long-term Survival for Patients Undergoing Volatile versus IV Anesthesia for Cancer Surgery: A Retrospective Analysis. Anesthesiology, 124(1), 69–79. https://doi.org/10.1097/ALN.0000000000000936
Wu, Z.-F., Lee, M.-S., Wong, C.-S., Lu, C.-H., Huang, Y.-S., Lin, K.-T., Lou, Y.-S., Lin, C., Chang, Y.-C., & Lai, H.-C. (2018). Propofol-based Total Intravenous Anesthesia Is Associated with Better Survival Than Desflurane Anesthesia in Colon Cancer Surgery. Anesthesiology, 129(5), 932–941. https://doi.org/10.1097/ALN.0000000000002357
Zheng, X., Wang, Y., Dong, L., Zhao, S., Wang, L., Chen, H., Xu, Y., & Wang, G. (2018, March 1). Effects of propofol-based total intravenous anesthesia on gastric cancer: a retrospective study. OncoTargets and Therapy. https://doi.org/10.2147/OTT.S156792 Download
Hiller, J. G., Perry, N. J., Poulogiannis, G., Riedel, B., & Sloan, E. K. (2018). Perioperative events influence cancer recurrence risk after surgery. Nature Reviews Clinical Oncology, 15(4), 205–218. https://doi.org/10.1038/nrclinonc.2017.194 Download
Sekandarzad, M. W., van Zundert, A. A. J., Lirk, P. B., Doornebal, C. W., & Hollmann, M. W. (2017). Perioperative Anesthesia Care and Tumor Progression. Anesthesia & Analgesia, 124(5), 1697. https://doi.org/10.1213/ANE.0000000000001652